Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
GIP Receptor Activation Glucose-dependent insulinotropic polypeptide (GIP) is the second target
injection of either L2-Cmu or vehicle
Choosing Wisely: Which Patients Benefit Most Clinicians often meet patients carrying different goals: metabolic control, weight reduction, or glycemic stability
People taking GLP-1 medications commonly report reduced food cravings, less emotional eating, and a quieting of the constant mental preoccupation with food that researchers call "food noise." Animal studies have also shown that GLP-1 receptor activation reduces the rewarding properties of high-calorie food in the brain findings confirmed in a landmark randomized, placebo-controlled neuroimaging study in humans ( van Bloemendaal et al., Diabetes, 2014 )
Use medications only as directed by your clinician
US$ 26.04
US$ 28.36
US$ 20.45
US$ 28.75
